These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17874864

  • 1. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW, Palmieri J, Khalsa M, Stebbins M.
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS, Daniel GW, Bullano MF, Kamal-Bahl S, Sajjan SG, Hu H, Alexander C.
    J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
    [Abstract] [Full Text] [Related]

  • 4. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.
    Fox D, Ried LD, Klein GE, Myers W, Foli K.
    J Am Pharm Assoc (2003); 2009 Oct; 49(2):192-9. PubMed ID: 19289345
    [Abstract] [Full Text] [Related]

  • 5. Pay for performance for hospitals.
    Mathes T, Pieper D, Morche J, Polus S, Jaschinski T, Eikermann M.
    Cochrane Database Syst Rev; 2019 Jul 05; 7(7):CD011156. PubMed ID: 31276606
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pay-for-performance for shared care of diabetes in Taiwan.
    Lee IT, Hsu CC, Sheu WH, Su SL, Wu YL, Lin SY.
    J Formos Med Assoc; 2019 Nov 05; 118 Suppl 2():S122-S129. PubMed ID: 31471222
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria.
    Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R.
    Diabetes Care; 2002 Apr 05; 25(4):684-9. PubMed ID: 11919125
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.
    Hsieh HM, Tsai SL, Mau LW, Chiu HC.
    Health Serv Res; 2016 Apr 05; 51(2):667-86. PubMed ID: 26152649
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA, Egger A.
    J Manag Care Pharm; 2006 Apr 05; 12(9):745-51. PubMed ID: 17249907
    [Abstract] [Full Text] [Related]

  • 19. Merging P4P and disease management: how do you know which one is working?
    Smith AL.
    J Manag Care Pharm; 2007 Mar 05; 13(2 Suppl B):S7-10. PubMed ID: 17341140
    [Abstract] [Full Text] [Related]

  • 20. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
    Tan EC, Pwu RF, Chen DR, Yang MC.
    Qual Life Res; 2014 Mar 05; 23(2):687-96. PubMed ID: 23975377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.